Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
ConditionOveractive Bladder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorYin Ping
About this trial
Through a scientific and standardized multicenter, blinding, double-dummy, randomized controlled, noninferiority clinical trial study method, the investigators evaluated electroacupuncture as a safe and effective non-pharmacological treatment for OAB in women by comparison with Solifenacin Succinate.
Eligibility criteria
Qualifiers
Meet the American Urological Association (AUA) diagnostic criteria for adult overactive bladder disorder (non-neurogenic) and the Chinese Urological Association's Guidelines for the Diagnosis and Treatment of Urological Diseases in China (2014 edition) for OAB.
Female patients aged 18-75 years.
Duration of illness with OAB ≥ 3 months.
3≤OABSS≤11.
Disqualifiers
Combination of more serious heart, liver, kidney and other serious diseases; Or patients with severe liver or kidney insufficiency.
Patients with pelvic organ prolapse ≥ Ⅱ degree, urinary system surgery history or pelvic floor surgery history.
Patients with other diseases presenting with OAB symptoms.
Those with urinary diseases (such as calculi and tuberculosis of the bladder), malignant tumors, and neurological disorders.
Trial design
Treatments tested in this trial
- electroacupuncture
- Solifenacin Succinate Tablets
Treatment groups
204 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yin Ping
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Sponsor institution
Longhua Hospital
Collaborator
Source ClinicalTrials.gov